The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $387,500 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to Texas Tech University Health Sciences Center (TTUHSC) on March 1, 2025. The grant supports research to identify novel lead EphB1/2 tyrosine kinase inhibitors targeting peripheral neuropathic pain. The project aims to advance scientific understanding of neural mechanisms and develop potential therapeutic interventions for neuropathic pain conditions. As a sub-awardee, TTUHSC has contributed to federally-funded biomedical research initiatives in areas like microbial biofilms, antimicrobial therapies, and animal models of neurological disorders. The grant award demonstrates NINDS's commitment to supporting extramural neuroscience research at academic institutions to improve treatment of neurological diseases and disorders.
Generated 3/18/25, 3:08 AM